All Sauce from Weekly Gravy:

Overuse of marijuana is increasingly being linked to dangerous bouts of psychosis, and a new study finds that antipsychotics may be needed to keep such patients out of the hospital. Psychotic episodes involve a dangerous psychiatric state in which people lose their connection with reality. These episodes can get so out of control that people may need hospitalization. However, new research finds that people who overuse marijuana and then experience their first psychotic episode may be helped by the quick use of injected antipsychotics. “These findings encourage the early use of second-generation, long-acting injectables as an important secondary pre­vention strategy to reduce rates of hospitalization” in such patients, reports a team led by Dr. Alexander Denissoff, of the University of Turku in Finland. His team tracked outcomes for 1,820 people who had a first psychotic episode and also had cannabis use disorder between 2006 and 2021. Just over 1,100 of these patients ended up being hospitalized due to “psychotic relapse,” according to the American Psychiatric Association news release. However, folks who had received any antipsychotic med were a third less likely to require hospitalization due to relapse, compared to those who hadn’t gotten these drugs. Comparing the effectiveness of various antipsychotics, risperidone came out on top, cutting the odds for relapse-linked hospitalization by 60%, the researchers found, followed by aripiprazole (58% reduction), oral clozapine (57%),…  read on >  read on >

A test to gauge if it’s safe to prescribe a patient an addictive opioid may have been approved too soon by the U.S. Food and Drug Administration, claims a letter sent to the agency by a group of experts. The test, called AvertD, is meant to screen for genetic markers suggesting that a person has a higher likelihood of developing an opioid use disorder (OUD). If the test result is positive, doctors could try alternative medications. However, the FDA approved the test in December against the advice of its own advisory panel, the experts noted in their letter. They claim that AvertD is inaccurate and could actually lead to more opioid dependencies, not less. “This test will make the opioid crisis worse,” said Dr. Andrew Kolodny, medical director of opioid policy research at Brandeis University in Massachusetts and one of the those who signed the letter. “It will contribute to overprescribing, it will contribute to an increased incidence of opioid use disorder,” he told NBC News. “In other words, more people becoming newly addicted to opioids.” He and the letter co-authors asked FDA Commissioner Robert Califf  to revoke the agency’s approval. Neither the FDA nor the test’s maker, California-based SOLVD Health, responded to NBC News for comment. According to data from the Substance Abuse and Mental Health Services Administration, over 6.1 million Americans were reported…  read on >  read on >

(HealthDayNews) — Following disappointing trial results, the maker of a controversial ALS drug said it is pulling the medication off the market. In a statement issued Thursday, Amylyx Pharmaceuticals said that Relyvrio failed to help patients in a large follow-up study, and the drug “will no longer be available for new patients as of today.” The medication is sold as Albrioza in Canada. “The decision to remove RELYVRIO/ALBRIOZA from the market and provide therapy free of charge for those who wish to continue was informed by the PHOENIX trial results, engagement with regulatory authorities and discussions with the ALS community,” Joshua Cohen and Justin Klee, co-CEOs of Amylyx, said in the statement. “Thank you to each and every person who shared feedback with us and continues to support our commitment to the ALS community.” The company added that, as of Thursday, “patients currently on therapy in the U.S. and Canada who, in consultation with their physician, wish to continue can be transitioned to a free drug program.” Relyvrio combines two older drugs: a prescription medication for liver disorders and a dietary supplement associated with traditional Chinese medicine. According to the New York Times, about 4,000 patients battling ALS are currently using Relyvrio, which has a list price of $154,000 per year. Relyvrio was first approved by the U.S. Food and Drug Administration in September 2022,…  read on >  read on >

A good night’s sleep is often hampered by caffeine, hunger, alcohol or chronic pain. Now, America has a new cause of poor sleep: the sound of gunfire on city streets. New research shows that gunshots are twice as likely to occur at night, mostly affecting the sleep of people in low-income neighborhoods. In fact, nearly three out of four gunshots (72%) occur at night in major U.S. cities, mostly on Saturday and Sunday, researchers found. “A nighttime gunshot likely disrupts the sleep of nearby community residents due to the sheer sound of the shot, which is then followed by a cacophony of sirens from police vehicles and ambulances,” said researcher Rebecca Robbins, an assistant professor of sleep medicine at Brigham and Women’s Hospital in Boston. For the study, researchers analyzed more than 72,000 records on the time and location of gunshots in six major cities around the United States, including Baltimore, Boston, New York, Philadelphia, Portland, Ore., and Washington, D.C., between 2015 and 2021. The team tracked how many gunshots occurred during the day versus at night, and then created maps to show which neighborhoods are most plagued by nighttime gunfire. They also estimated the number of people who lived near a location where gunshots occurred. As many as 12.5 million nights of sleep were ruined by gunfire across the six cities, given the number…  read on >  read on >

Women who enter menopause before their 50s and who also have heart disease risk factors may be at especially high risk for thinking declines and later dementia, new research shows. “While cardiovascular risk factors are known to increase a person’s risk for dementia, what is lesser known is why women have a greater risk for Alzheimer’s disease than men,” said study lead author Jennifer Rabin, of the University of Toronto. “We examined if the hormonal change of menopause, specifically the timing of menopause, may play a role in this increased risk.” Rabin’s team found that it did. “We found that going through this hormonal change earlier in life while also having cardiovascular risk factors is linked to greater cognitive problems when compared to men of the same age,” she explained in a news release from the American Neurological Association. Maintaining good blood flow to and within the brain is a known factor in neurological health. High blood pressure, smoking and diabetes can all impair brain blood flow. In the new study, Rabin’s team tracked the cognitive health of 16,720 people, averaging 65 years of age, evenly divided as to gender. They further divided the female participants into three subgroups: Those who experienced earlier menopause between the ages of 35 and 48; those who entered menopause between ages 49 and 52 (which is typical); and those…  read on >  read on >

A rotten work schedule in young adulthood can affect a person’s middle-aged health, a new study finds. Young adults who worked shifts outside the usual 9-to-5 schedule were more likely to report worse sleep and symptoms of depression in their 50s, researchers discovered. “Work that is supposed to bring resources to help us sustain a decent life has now become a vulnerability to a healthy life,” said researcher Wen-Jui Han, a professor with New York University. For the study, Han and her colleagues analyzed data from a long-term study that tracked the health of more than 7,000 people in the United States for more than three decades. Results showed that in their 20s through their 40s, people rarely have a straight 9-to-5 schedule. “Indeed, about three-quarters of the work patterns we observed did not strictly conform to working stably during daytime hours throughout our working years,” Han said in a university news release. “This has repercussions.” These sort of volatile work hours are associated with bad sleep, physical fatigue and emotional exhaustion, all of which can contribute to poor health, Han said. “People with work patterns involving any degree of volatility and variability were more likely to have fewer hours of sleep per day, lower sleep quality, lower physical and mental functions, and a higher likelihood of reporting poor health and depressive symptoms at age…  read on >  read on >

Two newly discovered genetic variations can have a powerful effect on a person’s risk for obesity, a new report says. Variants in the gene BSN, also known as Bassoon, can increase risk of obesity as much as sixfold, researchers report April 4 in the journal Nature Genetics. These variants affect about 1 in every 6,500 adults, researchers said. Variants of the APBA1 gene also are associated with increased obesity risk, results show. “We have identified two genes with variants that have the most profound impact on obesity risk at a population level we’ve ever seen,” said researcher Giles Yeo, a professor with the Medical Research Council’s Metabolic Diseases Unit at Cambridge University. Previous genetic variants associated with obesity have been linked to the brain pathways normally associated with appetite regulation, known as the leptin-melanocortin pathway, researchers said. Interestingly, neither the BSN nor the APBA1 gene are known to be involved in that brain pathway, researchers said. Instead, prior studies have found that these genes play a role in the transmission of signals between brain cells — suggesting that age-related brain declines might affect appetite control. Further, neither gene is associated with childhood obesity risk, researchers said. For the study, researchers used data from the UK Biobank genetic research project to perform genetic sequencing of body mass index in more than a half-million people. They found…  read on >  read on >

Desks that require folks to stand or move as they work also might help them produce better results on the job, a new study suggests. People’s brains became sharper when working at a desk that made them stand, step or walk rather than sit, results show. Reasoning scores in particular improved when at an active workstation, researchers said. “It is feasible to blend movement with office work that previously would have been done during long periods of sitting,” said senior study author Dr. Francisco Lopez-Jimenez, a preventive cardiologist with the Mayo Clinic. “Active workstations may offer a way to potentially improve cognitive performance and overall health, simply by moving at work.”  For the study, researchers recruited 44 participants to test four different office settings during four consecutive days. The first day, people sat at a typical desk for work. The next three days, they worked at an elevated desk, either standing, walking on a treadmill or using a stepper. Typing speed slowed down slightly at active workstations, but the accuracy of their typing was not affected, researchers found. On the other hand, tests revealed that their brain function either improved or stayed the same when they were active while working. The participants scored better on reasoning tests when standing, stepping or walking, compared to sitting, results show. The new study was published April 4 in…  read on >  read on >

Three anti-smoking groups announced Tuesday that they have sued the U.S. government yet again after it missed its latest deadline for enacting a ban on menthol cigarettes. This is the second lawsuit that the plaintiffs — the African American Tobacco Control Leadership Council, Action on Smoking and Health and the National Medical Association — have filed against the U.S. Food and Drug Administration over delays in banning menthol cigarettes. The first lawsuit, filed in 2020, demanded that the FDA add menthol to its list of prohibited flavors for public health reasons. Once the agency began to take action on the issue, that lawsuit was dismissed. In the latest lawsuit, the groups claim the agency missed a March deadline for issuing a final rule on a menthol ban. Menthol cigarettes are particularly popular in the Black community. “Because of defendants’ inaction, tobacco companies have continued to use menthol cigarettes to target youth, women and the Black community — all to the detriment of public health,” the lawsuit stated. “As African American physicians, we are deeply disturbed at the continuing delays in FDA’s finalizing of the ban on menthol cigarettes,” Dr. Yolanda Lawson, president of the National Medical Association, said in a news release announcing the lawsuit. “Our patients, more than any other group, become disabled and die prematurely due to the continued use of these cigarettes.”…  read on >  read on >

Research into germs that travel through the human digestive tract shows that some may promote obesity while others might help prevent it. Not only that, but those microbes may act differently in men versus women, the same study found. “Our findings reveal how an imbalance in distinct bacterial groups are likely to play an important role in the onset and development of obesity, with considerable differences between the sexes,” said study lead author Dr Paula Aranaz, from the Centre for Nutrition Research at the University of Navarra in Spain. Her team is slated to present the findings in May at the European Congress on Obesity in Venice. The researchers focused on an end product of human digestion: poop. They carefully analyzed the “metabolome” of stool samples from 251 female and 110 male adult volunteers, averaging 44 years of age. The metabolome is the variety of metabolite molecules that form as gut bacteria break down food, the researchers explained in a meeting news release. Aranaz’ team also used genetic profiling to identify the various types of bacteria in the stool samples. The participants ran the gamut in terms of weight — 65 were normal weight, 110 were overweight and 186 were deemed obese. Certain microbial patterns emerged when it came to correlations between gut microbes and weight. For example, folks who were obese tended to have…  read on >  read on >